Home | All results_reference

[RDF data]
Results Reference #1344

Resource URI: http://static.linkedct.org/resource/results_reference/1344
linkedct:citation Pan C, Hussey M, Lara P, et al.: Phase II trial of the epidermal growth factor receptor (EGFR) inhibitor erlotinib (E) in patients (pts) with advanced papillary renal cell carcinoma (pRCC): SWOG S0317. [Abstract] J Clin Oncol 25 (Suppl 18): A-15516, 651s, 2007.
rdfs:label Results Reference #1344
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00060307>
linkedct:results_reference_id 1344 (xsd:int)
rdf:type linkedct:results_reference